Bioventus (BVS) Interest Expenses (2020 - 2026)

Bioventus' Interest Expenses history runs 7 years deep, the most recent figure standing at $938000.0 for Q1 2026.

• Quarterly Interest Expenses rose 5.16% year-over-year to $938000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $61.2 million (down 7.09% YoY) and the FY2025 annual result came in at $47.6 million, down 8.28% from the prior year.
• Interest Expenses was $938000.0 for Q1 2026 at Bioventus, down from $24.4 million in the prior quarter.
• Across five years, Interest Expenses topped out at $35.0 million in Q4 2024 and bottomed at $203000.0 in Q4 2022.
• A 5-year average of $14.2 million and a median of $14.5 million in 2022 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses plunged 98.73% — and 2023, when it soared 9805.91%.
• Bioventus' Interest Expenses stood at $14.5 million in 2022, then surged by 98.2% to $28.8 million in 2023, then climbed by 21.72% to $35.0 million in 2024, then slumped by 30.5% to $24.4 million in 2025, then slumped by 96.15% to $938000.0 in 2026.
• Business Quant data shows BVS's Interest Expenses at $938000.0 in Q1 2026, $24.4 million in Q4 2025, and $5.9 million in Q3 2025.